Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 21344-24-1 | MDL No. : | MFCD18254753 |
Formula : | C7H4BrNS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YMOORGYWRBQPDZ-UHFFFAOYSA-N |
M.W : | 214.08 | Pubchem ID : | 12885487 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.32 |
TPSA : | 41.13 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.55 cm/s |
Log Po/w (iLOGP) : | 2.12 |
Log Po/w (XLOGP3) : | 2.89 |
Log Po/w (WLOGP) : | 3.06 |
Log Po/w (MLOGP) : | 2.27 |
Log Po/w (SILICOS-IT) : | 3.87 |
Consensus Log Po/w : | 2.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.65 |
Solubility : | 0.0475 mg/ml ; 0.000222 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.41 |
Solubility : | 0.0825 mg/ml ; 0.000386 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.83 |
Solubility : | 0.0317 mg/ml ; 0.000148 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.95 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With copper(ll) bromide; isopentyl nitrite In acetonitrile at 20℃; | Example 16E 5-Bromothieno[2,3-b]pyridine The product of Example 16D (1.35 g. 9.0 mmol) was treated with iso-amylnitrite (Aldrich. 2.10 g. 18.0 mmol) and CuBr2 (Aldrich, 4.03 g. 18.0 mmol) in MeCN (20 mL) at ambient temperature overnight. The reaction mixture was quenched with saturated NH4Cl (20 mL) and then extracted with EtOAc (3*50 mL). The combined extracts were washed with brine (2*30 mL) and concentrated. The residue was purified with chromatography (SiO2, EtOAc/hexane, v. 80/20. Rf=0.80) to give the title compound (1.03 g, yield, 53.0percent). 1H NMR (300 MHz, CDCl3) 8 ppm 7.22 (d, J=6.10 Hz, 1H), 7.58 (d, J=6.10 Hz, 1H). 8.21 (d, J=2.37 Hz, 1H), 8.61 (d, J=2.0(3 Hz, 1H):MS (DCI/NH3) m/z 214 (M+1)+, 216 (M+1)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | at 150℃; | (C) To a solution of 971 5-bromothieno[2,3-b]pyridine-2-carboxylic acid (6.6 g, 25.6 mmol) in 973 DMA (50 mL) was added 974 DBU (12.8 g, 84.1 mmol) and the resulting mixture was stirred at 150° C. overnight. After cooling to rt, the reaction was quenched with 444 H2O (100 mL) and the resulting mixture was extracted with EtOAc (3×100 mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. The residue thus obtained was purified by silica gel chromatography (0-10percent EtOAc/petroleum ether) to afford 975 5-bromothieno[2,3-b]pyridine (3.3 g, 60percent), as a white solid. LC/MS: mass calcd. for C7H4BrNS: 212.92, found: 213.8, 215.8 [M+H, M+H+2]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3% | With hydrogenchloride In ethanol at 105℃; for 24 h; Inert atmosphere | To a solution of tert-butyl thiophen-2-ylcarbamate (3.0 g, 15 mmol) and 2-bromomalonaldehyde (2.57 g, 17 mmol) in EtOH (30 mL) was added concentrated HC1 (7.5 mL) under N2. The reaction mixture was heated to 105 oC for 24 h. After cooling to rt, the reaction mixture was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography eluting with 2percent MeOH in DCM to give 5-bromothieno[2,3-b]pyridine as a yellow solid (90 mg, 3percent). 1H NMR (300 MHz, CDC13 8.60 (d, J = 2.1 Hz, 1H), 8.11 (d, J = 2.4 Hz, 1H), 7.55-7.60 (m, 1H), 7.19-7.22 (m, 1H). LC-MS (ESI) mlz 215 (M+H)+. |
[ 1379322-62-9 ]
5-Bromothieno[2,3-d]pyrimidine
Similarity: 0.72
[ 1379322-62-9 ]
5-Bromothieno[2,3-d]pyrimidine
Similarity: 0.72
[ 53174-98-4 ]
Thieno[2,3-b]pyridine-2-carbaldehyde
Similarity: 0.71